Debbie Wasserman Schultz actually said...

As a breast cancer survivor, the exceptionally high cost of cancer drugs is an issue where the policy is very personal for me.

Congress should reject that false choice and act now to rein in the era of the greed of pharmaceutical companies.

We can have both innovative treatments and affordable prices, and we all deserve both.

No one should be unable to afford life-saving medication, but 42 percent of cancer patients deplete their entire net worth.